Browse > Article
http://dx.doi.org/10.4014/jmb.2106.06039

Microbiota of Breast Tissue and Its Potential Association with Regional Recurrence of Breast Cancer in Korean Women  

Kim, Hyo-Eun (Department of Life Science, Multidisciplinary Genome Institute, Hallym University)
Kim, Jongjin (Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center)
Maeng, Sejung (Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center)
Oh, Bumjo (Department of Family Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center)
Hwang, Ki-Tae (Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center)
Kim, Bong-Soo (Department of Life Science, Multidisciplinary Genome Institute, Hallym University)
Publication Information
Journal of Microbiology and Biotechnology / v.31, no.12, 2021 , pp. 1643-1655 More about this Journal
Abstract
Recent studies have reported dysbiosis of the microbiome in breast tissue collected from patients with breast cancer and the association between the microbiota and disease progression. However, the role of the microbiota in breast tissue remains unclear, possibly due to the complexity of breast cancer and various factors, including racial and geographical differences, influencing microbiota in breast tissue. Here, to determine the potential role of microbiota in breast tumor tissue, we analyzed 141 tissue samples based on three different tissue types (tumor, adjacent normal, and lymph node tissues) from the same patients with breast cancer in Korea. The microbiota was not simply distinguishable based on tissue types. However, the microbiota could be divided into two cluster types, even within the same tissue type, and the clinicopathologic factors were differently correlated in the two cluster types. Risk of regional recurrence was also significantly different between the microbiota cluster types (p = 0.014). In predicted function analysis, the pentose and glucuronate interconversions were significantly different between the cluster types (q < 0.001), and Enterococcus was the main genus contributing to these differences (q < 0.01). Results showed that the microbiota of breast tissue could interact with the host and influence the risk of regional recurrence. Although further studies would be recommended to validate our results, this study could expand our understanding on the breast tissue microbiota, and the results might be applied to develop novel prediction methods and treatments for patients with breast cancer.
Keywords
Breast cancer; tissue microbiota; regional recurrence; microbiota cluster; Enterococcus;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Xavier JB, Young VB, Skufca J, Ginty F, Testerman T, Pearson AT, et al. 2020. The cancer microbiome: Distinguishing direct and indirect effects requires a systemic view. Trends Cancer 6: 192-204.   DOI
2 Kameoka S, Motooka D, Watanabe S, Kubo R, Jung N, Midorikawa Y, et al. 2021. Benchmark of 16S rRNA gene amplicon sequencing using Japanese gut microbiome data from the V1-V2 and V3-V4 primer sets. BMC Genomics 22: 527.   DOI
3 Lee MJ, Kang MJ, Lee SY, Lee E, Kim K, Won S, et al. 2018. Perturbations of gut microbiome genes in infants with atopic dermatitis according to feeding type. J. Allergy Clin. Immunol. 141: 1310-1319.   DOI
4 Vetrovsky T, Baldrian P. 2013. The variability of the 16S rRNA gene in bacterial genomes and its consequences for bacterial community analyses. PLoS One 8: e57923.   DOI
5 Human Microbiome Project C. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214.   DOI
6 Kristich CJ, Rice LB, Arias CA. 2014. Enterococcal infection-treatment and antibiotic resistance, pp. 87-134. In Gilmore MS, Clewell DB, Ike Y, Shankar N (eds.), Enterococci: From commensals to leading causes of drug resistant infection, Ed. Massachusetts Eye and Ear Infirmary, Boston, USA.
7 Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. 2018. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360: eaan5931.   DOI
8 Yan X, Yang M, Liu J, Gao R, Hu J, Li J, et al. 2015. Discovery and validation of potential bacterial biomarkers for lung cancer. Am. J. Cancer Res. 5: 3111-3122.
9 Hassan Z, Mustafa S, Rahim RA, Isa NM. 2016. Anti-breast cancer effects of live, heat-killed and cytoplasmic fractions of Enterococcus faecalis and Staphylococcus hominis isolated from human breast milk. In Vitro Cell Dev. Biol. Anim. 52: 337-348.   DOI
10 Fearon ER. 2011. Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 6: 479-507.   DOI
11 Oikari S, Kettunen T, Tiainen S, Hayrinen J, Masarwah A, Sudah M, et al. 2018. UDP-sugar accumulation drives hyaluronan synthesis in breast cancer. Matrix Biol. 67: 63-74.   DOI
12 Arnold JM, Gu F, Ambati CR, Rasaily U, Ramirez-Pena E, Joseph R, et al. 2019. UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression. Oncogene 39: 3089-3101.
13 Fuster MM, Esko JD. 2005. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 5: 526-542.   DOI
14 Connelly MA, Gruppen EG, Otvos JD, Dullaart RPF. 2016. Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer. Clin. Chim. Acta 459: 177-186.   DOI
15 Furukawa K, Ohmi Y, Ohkawa Y, Bhuiyan RH, Zhang P, Tajima O, et al. 2019. New era of research on cancer-associated glycosphingolipids. Cancer Sci. 110: 1544-1551.   DOI
16 Prodan A, Tremaroli V, Brolin H, Zwinderman AH, Nieuwdorp M, Levin E. 2020. Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing. PLoS One 15: e0227434.   DOI
17 Tarp MA, Clausen H. 2008. Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim. Biophys. Acta 1780: 546-563.   DOI
18 Daillere R, Vetizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, et al. 2016. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity 45: 931-943.   DOI
19 Huycke MM, Abrams V, Moore DR. 2002. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23: 529-536.   DOI
20 Rosario SR, Long MD, Affronti HC, Rowsam AM, Eng KH, Smiraglia DJ. 2018. Pan-cancer analysis of transcriptional metabolic dysregulation using the cancer genome atlas. Nat. Commun. 9: 5330.   DOI
21 Yu Y, Champer J, Beynet D, Kim J, Friedman AJ. 2015. The role of the cutaneous microbiome in skin cancer: lessons learned from the gut. J. Drugs Dermatol. 14: 461-465.
22 Urbaniak C, Burton JP, Reid G. 2012. Breast, milk and microbes: a complex relationship that does not end with lactation. Womens Health (Lond) 8: 385-398.   DOI
23 Meng S, Chen B, Yang J, Wang J, Zhu D, Meng Q, et al. 2018. Study of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy. Front. Oncol. 8: 318.   DOI
24 Kwa M, Plottel CS, Blaser MJ, Adams S. 2016. The intestinal microbiome and estrogen receptor-positive female breast cancer. J. Natl. Cancer Inst. 108: djw029.
25 Selber-Hnatiw S, Rukundo B, Ahmadi M, Akoubi H, Al-Bizri H, Aliu AF, et al. 2017. Human gut microbiota: Toward an ecology of disease. Front. Microbiol. 8: 1265.   DOI
26 Wang H, Altemus J, Niazi F, Green H, Calhoun BC, Sturgis C, et al. 2017. Breast tissue, oral and urinary microbiomes in breast cancer. Oncotarget 8: 88122-88138.   DOI
27 DeStefano Shields CE, Van Meerbeke SW, Housseau F, Wang H, Huso DL, Casero RA, Jr., et al. 2016. Reduction of murine colon tumorigenesis driven by enterotoxigenic Bacteroides fragilis using cefoxitin treatment. J. Infect. Dis. 214: 122-129.   DOI
28 Goedert JJ, Jones G, Hua X, Xu X, Yu G, Flores R, et al. 2015. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J. Natl. Cancer Inst. 107: djv147.
29 Xuan C, Shamonki JM, Chung A, DiNome ML, Chung M, Sieling PA, et al. 2014. Microbial dysbiosis is associated with human breast cancer. PLoS One 9: e83744.   DOI
30 Singh K, Tantravahi U, Lomme MM, Pasquariello T, Steinhoff M, Sung CJ. 2016. Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers. Breast Cancer Res. Treat. 157: 405-411.   DOI
31 Zeng F, Fu J, Hu F, Tang Y, Fang X, Zeng F, et al. 2018. Identification of key pathways and genes in response to trastuzumab treatment in breast cancer using bioinformatics analysis. Oncotarget 9: 32149-32160.   DOI
32 Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, et al. 2014. Microbiota of human breast tissue. Appl. Environ. Microbiol. 80: 3007-3014.   DOI
33 Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, et al. 2016. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci. Rep. 6: 30751.   DOI
34 Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G. 2016. The microbiota of breast tissue and its association with breast cancer. Appl. Environ. Microbiol. 82: 5039-5048.   DOI
35 Chan AA, Bashir M, Rivas MN, Duvall K, Sieling PA, Pieber TR, et al. 2016. Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors. Sci. Rep. 6: 28061.   DOI
36 Bukin YS, Galachyants YP, Morozov IV, Bukin SV, Zakharenko AS, Zemskaya TI. 2019. The effect of 16S rRNA region choice on bacterial community metabarcoding results. Sci. Data 6: 190007.   DOI
37 Edgar RC. 2013. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10: 996-998.   DOI
38 Yazdi HR, Movafagh A, Fallah F, Alizadeh Shargh S, Mansouri N, Heidary Pour A, et al. 2016. Evaluation of Methylobacterium radiotolerance and Sphyngomonas yanoikoaie in sentinel lymph nodes of breast cancer cases. Asian Pac. J. Cancer Prev. 17: 279-285.   DOI
39 Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, et al. 2020. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368: 973-980.   DOI
40 Smith A, Pierre JF, Makowski L, Tolley E, Lyn-Cook B, Lu L, et al. 2019. Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women. Sci. Rep. 9: 11940.   DOI
41 Kim HE, Lee JJ, Lee MJ, Kim BS. 2019. Analysis of microbiome in raw chicken meat from butcher shops and packaged products in South Korea to detect the potential risk of foodborne illness. Food Res. Int. 122: 517-527.   DOI
42 Park JU, Oh B, Lee JP, Choi MH, Lee MJ, Kim BS. 2019. Influence of microbiota on diabetic foot wound in comparison with adjacent normal skin based on the clinical features. Biomed. Res. Int. 2019: 7459236.
43 Schwabe RF, Jobin C. 2013. The microbiome and cancer. Nat. Rev. Cancer 13: 800-812.   DOI
44 Grice EA, Segre JA. 2012. The human microbiome: our second genome. Annu. Rev. Genomics Hum. Genet. 13: 151-170.   DOI
45 Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. 2010. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 28: 2784-2795.   DOI
46 Lluch J, Servant F, Paisse S, Valle C, Valiere S, Kuchly C, et al. 2015. The characterization of novel tissue microbiota using an optimized 16S metagenomic sequencing pipeline. PLoS One 10: e0142334.   DOI
47 Barnes BB, Steindorf K, Hein R, Flesch-Janys D, Chang-Claude J. 2011. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors. Cancer Epidemiol. 35: 345-352.   DOI
48 Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75: 7537-7541.   DOI
49 Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. 2011. Metagenomic biomarker discovery and explanation. Genome Biol. 12: R60.   DOI
50 Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics, 2019. CA Cancer J. Clin. 69: 7-34.   DOI
51 Sampson JN, Falk RT, Schairer C, Moore SC, Fuhrman BJ, Dallal CM, et al. 2017. Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women. Cancer Res. 77: 918-925.   DOI
52 Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. 2014. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 12: 87.   DOI
53 Qiu J, Du Z, Liu J, Zhou Y, Liang F, Lu Q. 2018. Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: A prospective case-control study. Medicine (Baltimore) 97: e13337.   DOI
54 Yoon SH, Ha SM, Kwon S, Lim J, Kim Y, Seo H, et al. 2017. Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies. Int. J. Syst. Evol. Microbiol. 67: 1613-1617.   DOI
55 Parks DH, Tyson GW, Hugenholtz P, Beiko RG. 2014. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 30: 3123-3124.   DOI
56 DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. 2016. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J. Clin. 66: 31-42.   DOI
57 Alcantara VS, Lim GH, Lim SH, Sultana R, Lee JA. 2017. Incidence and prognosis of non-metastatic triple negative breast cancer (TNBC) among different races in Southeast Asia. J. Surg. Oncol. 115: 523-537.   DOI
58 Chaudhary K, Poirion OB, Lu L, Garmire LX. 2018. Deep learning-based multi-omics integration robustly predicts survival in liver cancer. Clin. Cancer Res. 24: 1248-1259.   DOI
59 Arias CA, Murray BE. 2012. The rise of the Enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol. 10: 266-278.   DOI